Collegium Pharmaceutical Launched ADHD Resource Hub

The new online platform provides tools to help patients and caregivers prepare for medical and school-related discussions.

Updated on Oct. 6, 2026 in Autism

Isometric editorial illustration of nesting geometric blocks representing daily phases, evoking structured planning for health communication. — Collegium Pharmaceutical has launched the 'Start Talking ADHD' online hub, offering tools to help patients and caregivers document daily challenges for providers. AI Illustration. Upload story photo >

Live Poll

Do you feel you have access to enough practical support when navigating healthcare and school systems?

Collegium Pharmaceutical has introduced a new online resource hub called Start Talking ADHD to assist patients and caregivers in managing conversations with providers and educators. The hub offers downloadable guides and checklists aimed at facilitating clearer communication regarding the daily needs of those with the condition.

Why it matters

Managing ADHD often requires navigating complex medical and educational systems, and these tools are designed to help users articulate daily challenges to school administrators and healthcare professionals. The initiative aims to support more informed decision-making for a population that includes approximately 7 million children and 15.5 million adults in the U.S.

The new digital hub provides structured discussion guides and checklists based on the estimated national prevalence of ADHD among 22.5 million Americans. While the resources are designed to organize communication, the efficacy of these specific templates for clinical outcomes is currently unmeasured.

The players

Collegium Pharmaceutical

A Stoughton-based pharmaceutical company that develops treatments for pain and ADHD.

Boston Legacy Football Club

A professional sports organization that partnered with Collegium to sponsor sensory-friendly match environments.

The details

The Start Talking ADHD hub provides fill-in worksheets that prompt users to document daily experiences across various segments of time, including mornings, afternoons, and sleep cycles. By tracking these patterns, patients can provide healthcare providers and school officials with specific, data-backed evidence of their challenges. This information can then be used to support requests for 504 Plans or Individualized Education Programs (IEPs) within the school system.

February 2026: Collegium Pharmaceutical partnered with the Boston Legacy Football Club.
May 2026: The company added a second medicine to its ADHD portfolio.
October 6, 2026: The Start Talking ADHD resource hub was officially launched.

Health Landscape

This launch follows a broader industry trend of pharmaceutical companies providing patient-support ecosystems to accompany their core medical therapies. It sits at the intersection of clinical care and educational advocacy, addressing the need for structured communication in obtaining legal protections like Section 504 Plans.

If you or your child are managing ADHD, consider using these tracking tools to prepare for your next clinical visit or school meeting. It is worth discussing with your doctor how structured daily symptom tracking can specifically help document your individual needs for treatment or school support plans.

The takeaway

Using standardized checklists can help you transform subjective daily experiences into actionable evidence for your healthcare or school team. Consider keeping a simple log of your daily symptoms for a week prior to your next appointment to facilitate a more productive conversation with your physician.